1) The prescription of invigorating spleen and hemostasis
复芪功血方
1.
The prescription of invigorating spleen and hemostasis, which are consisted of Rananxnotoginseng, Astragalus membranaceus Bge and clinpodium polylephalum, was one of the treat methods for spleen tailing to control blood syndrome.
复芪功血方是季绍良教授的临床经验方，由黄芪、三七、断血流三味中药组成，对治疗脾不统血证功能失调性子宫出血有很好的疗效。
2) Qiqi formula
杞芪复方
3) ShenQi compound recipe
参芪复方
1.
Mechanism of ShenQi compound recipe on preserving vessel endothelium in GK rats;
参芪复方对自发性糖尿病大鼠血管内皮保护的作用机制
2.
Effect of Shenqi Compound Recipe on the Expression of PPARγ in White Adipose Tissue of Rats with Macrovascular Complication in Earlier Stage of Diabetes;
参芪复方对糖尿病早期大血管病变大鼠白色脂肪过氧化物酶体增生物激活受体γ的影响
3.
Mechanism of Shenqi compound recipe anti-earlier diabetic artherosclerosis in GK rats;
参芪复方抗自发性糖尿病GK大鼠早期动脉粥样硬化的作用机制
4) Huangqi compound
黄芪复方
1.
Objective To observe the mechanism of Huangqi compound by regulating the acetylcholine receptor antibody (AChRAb) level in blood of myasthenia gravis (MG) patients.
目的采用中药黄芪复方调节重症肌无力(myastheniagravis,MG)患者血清乙酰胆碱受体抗体(acetylcholinereceptorantibody,AChRAb)水平,以探讨其治疗MG的可能作用机制。
2.
Objective: To study the mechanism of HuangQi compound by regulating the level of interferongamma(IFN -γ) and it s mRNA in blood of myasthenia gravis patients.
目的:采用中药黄芪复方调控重症肌无力(myasthenia gravis,MG)患者血清干扰素-γ及其mR-NA表达水平,以探讨其治疗MG的可能作用机制。
3.
Objetive:To investigate effects of HuangQi compound on level of IL-4,IFN-γ,TGF-β,in Experimental Autoimmune Myasthenia Gravis Rats Blood,in order to study the treatment mechanism of HuangQi compund to EAMG.
目的 :观察黄芪复方对实验性自身免疫性重症肌无力大鼠血清IL -4、IFN -γ、TGF -β水平的影响 ,以探讨其治疗重症肌无力的可能机制。
5) Modified formula Radix hedysari et al
复方红芪
6) hongqi formular
红芪复方
1.
Objective:The hongqi formular is made up of astragalosides and safflor yellow.
目的:本实验旨在研究红花总黄酮与黄芪总皂苷配伍,观察红芪复方对犬急性心肌缺血的保护作用,同时为运动性心肌缺血的中药药物预适应保护研究提供实验依据。
补充资料：方功
1.指土方工程。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条